Who
Jarrett Disbrow
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Aytu BioPharma.
In numbers
- Trades disclosed
- 35
- Buys
- 5
- Sells
- 0
- Bought
- $577K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Nov 2015
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —19,606 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 9 Jun 2025filed 10 Jun 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $25K16,666 at $1.50 | filing |
| 6 Nov 2024filed 8 Nov 2024 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,000 at $0.00 | filing |
| 11 Aug 2023filed 15 Aug 2023 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,000 at $0.00 | filing |
| 24 Oct 2018filed 26 Oct 2018 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —337,500 | filing |
| 6 Mar 2018filed 7 Mar 2018 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —226,105 at $0.00 | filing |
| 6 Mar 2018filed 7 Mar 2018 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $102K226,105 at $0.45 | filing |
| 7 Nov 2017filed 9 Nov 2017 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —100,000 | filing |
| 15 Aug 2017filed 22 Aug 2017 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | $250K1,666,667 at $0.15 | filing |
| 15 Aug 2017filed 22 Aug 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | $450K2,500,000 at $0.18 | filing |
| 16 Mar 2017filed 22 Aug 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code D | —50,000 at $0.00 | filing |
| 16 Mar 2017filed 22 Aug 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code D | —60,000 at $0.00 | filing |
| 16 Mar 2017filed 22 Aug 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Mar 2017filed 22 Aug 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 16 Mar 2017filed 17 Mar 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code D | —50,000 at $0.00 | filing |
| 16 Mar 2017filed 17 Mar 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code D | —60,000 at $0.00 | filing |
| 16 Mar 2017filed 17 Mar 2017 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.